Numerous advocacy organizations are sounding the alarm over a recent HHS notice that restricts access to federal benefits for ...

Healthcare providers are making cybersecurity progress, but serious vulnerabilities remain — especially when it comes to AI ...

A group of Democratic attorneys general filed a lawsuit against HHS and CMS, arguing that their recent final rule will harm access to care under the Affordable Care Act.

Sarepta Therapeutics knew about the death of a patient treated with its experimental gene therapy for a type of limb-girdle muscular dystrophy, but said nothing publicly for a month. Financial ...

Sarepta’s Elevidys will remain on the market with a black box warning. But this gene therapy for Duchenne muscular dystrophy still faces commercial headwinds and analysts say the company has ...

Most patients are open to the use of AI in healthcare — as long as it enhances, rather than replaces, human interaction, according to new research. It also showed that patients want transparency ...

Hengrui’s peptide drug, HRS9531, is engineered to bind to and activate the GLP-1 and GIP receptors — the same two targets hit by blockbuster Eli Lilly’s chronic weight management drug ...